Ionis Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Ionis Pharmaceuticals Inc.
BB Biotech AG
8,516,334
6.2%
654,400
9.36%
03/31/2018
Fidelity Growth Company Fund
7,345,119
5.35%
-39,854
0.69%
07/31/2018
Ivy Science & Technology Fund
4,180,000
3.05%
0
2.22%
06/30/2018
Vanguard Small Cap Index Fund
3,158,199
2.29%
40,258
0.15%
07/31/2018
Vanguard Total Stock Market Index Fund
3,149,587
2.29%
20,280
0.02%
07/31/2018
Hartford Mid Cap Fund
2,844,496
2.06%
-26,654
0.98%
07/31/2018
ClearBridge Aggressive Growth Fund
2,777,852
2.02%
-12,718
1.03%
12/31/2017
Fidelity Select Biotechnology Portfolio
2,524,877
1.84%
0
1.25%
07/31/2018
Vanguard Health Care Fund
2,119,180
1.54%
0
0.19%
06/30/2018
Fidelity Series Growth Company Fund
2,104,782
1.53%
0
0.72%
07/31/2018
| Address |
2855 Gazelle Court
Carlsbad California 92010
United States
|
|
Employees
|
- |
| Website |
http://www.ionispharm.com |
| Updated |
07/08/2019 |
| Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. |
